Provided by Tiger Fintech (Singapore) Pte. Ltd.

Centessa Pharmaceuticals plc

13.03
+0.36002.84%
Post-market: 13.030.00000.00%16:41 EDT
Volume:566.02K
Turnover:7.37M
Market Cap:1.74B
PE:-6.33
High:13.50
Open:13.02
Low:12.85
Close:12.67
Loading ...
Sep 01, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 24, 2023

Major Issues Report

Form 8-K - Current report
Aug 14, 2023

Major Issues Report

Form 8-K - Current report
Aug 14, 2023

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 01, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jul 10, 2023

Major Issues Report

Form 8-K - Current report
Jul 03, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 23, 2023

Major Issues Report

Form 8-K - Current report
Jun 09, 2023

Major Issues Report

Form 8-K - Current report
Jun 01, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 24, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 22, 2023

Major Issues Report

Form 8-K - Current report
May 12, 2023

Major Issues Report

8-K - Current report
May 12, 2023

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
May 01, 2023

Proposed Sale Of Securities

144 - Report of proposed sale of securities
Apr 03, 2023

Proposed Sale Of Securities

144 - Report of proposed sale of securities
Mar 30, 2023

Employee Stock Ownership

S-8 - Securities to be offered to employees in employee benefit plans
Mar 30, 2023

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 30, 2023

Major Issues Report

8-K - Current report
Jan 31, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals